Health Condition 1: Q639- Congenital malformation of kidney,unspecified Health Condition 2: Q431- Hirschsprungs disease Health Condition 3: Q549- Hypospadias, unspecified Health Condition 4: 4- Measurement and Monitoring Health Condition 5: O- Medical and Surgical Health Condition 6: Q445- Other congenital malformations ofbile ducts Health Condition 7: N508- Other specified disorders of malegenital organs Health Condition 8: Q539- Undescended testicle, unspecified Health Condition 9: K409- Unila
Conditions
Interventions
Intervention1: Intravenous Lignocaine: Intravenous Lignocaine (1.5 mg/kg), given just prior to reversal of neuromuscular blockade to decrease the stress of extubation and avoid respiratory/ airway com
Sponsors
Mridul Dhar
Dr Yashwant Singh Payal
Eligibility
Inclusion criteria
Inclusion criteria: ASA- I-II Patients undergoing surgery under general anaesthesia
Exclusion criteria
Exclusion criteria: 1. Patients with known allergy to amide local anaesthetics 2. Patients with known seizure disorder 3. Known or expected difficult airway 4. Renal, hepatic or muscular disorders 5. Patients taking drugs affecting neuromuscular function
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Time from giving reversal and achieving TOF of 0.9 2.Time from giving reversal to extubating the trachea Timepoint: Every 12 seconds, from giving reversal to reaching TOF of 0.9 | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Any incidence of coughing, bucking, post-extubation laryngospasm, bronchospasm, hypoxemia, nausea, vomiting 2. Heart rate and BP will be recorded just after extubating the trachea and 5 minutes after extubation 3. TOF ratio at the time of clinical adequacy of extubationTimepoint: 1. Complications: Just after extubation to post op PACU 2. HR and BP, after extubation and 5 mins after | — |
Countries
India
Contacts
Public ContactMridul Dhar
All India Institute of Medical Sciences
Outcome results
None listed